Genetic mutation rate study may improve disease prediction

The building blocks of genetic prediction may carry a hidden flaw. A study published in the American Journal of Human Genetics finds that the tools researchers use to assess whether a genetic variant will cause disease have been misreading a fundamental signal in the genome.

Mutation rates are not uniform. Some regions of the genome mutate more readily than others, and the study's authors, Loay et al., found that most variant effect predictors interpret this variation as evidence of functional importance — when in fact it may simply reflect the underlying chemistry of DNA.

The result, the researchers reported, is a systematic bias in pathogenicity predictions: variants in low-mutation-rate regions are more likely to be flagged as dangerous, not necessarily because they are, but because those regions happen to be more stable. The study also found, through a technique called deep mutational scanning, evidence of genuine mutational robustness — meaning some genes can tolerate changes without loss of function, a finding that current tools tend to underestimate.

The authors propose that explicitly modelling the probability of a given mutation occurring, rather than treating all variants equally, would produce more accurate interpretations of what a variant actually does.

Why this may matter for people with albinism

Genetic variants in genes such as TYR, OCA2, TYRP1, and SLC45A2 are the basis for diagnosing different types of oculocutaneous albinism. Accurate pathogenicity prediction tools are central to that diagnostic process — and to genetic counselling for families.

If those tools carry the bias described by Loay et al., some variants associated with albinism may be mispredicted: incorrectly classified as benign, or flagged as harmful when they are not. The study does not examine albinism-related genes directly, but the methodological findings apply broadly across the genome.

Improved modelling of mutation probabilities, as the authors recommend, could over time sharpen the accuracy of albinism diagnoses and reduce the uncertainty that families often encounter when variant reports return ambiguous results.